Malaguarnera M, et al
Claims tied to non-prescription peptides' fat-loss benefits are often made without a cited study behind them, which makes their real-world results harder to predict than those of FDA-approved options
Knezevic, Gojkovic.S, Krezic.I, Zizek.H, Knezevic.T, Occluded Superior Mesenteric Artery and Vein
Peroxisome proliferator-activated receptor (PPAR) alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination
1971, sold Faberg in 1987) IVAC Corporation (acq
Human hearts with ischemic, dilated, and hypertrophic cardiomyopathy demonstrate upregulated GLP-1R expression in cardiomyocytes compared to non-failing hearts [2]